Identification and Validation of PCAT14 as Prognostic Biomarker in Prostate Cancer1
Under a Creative Commons license
open access
Cited by (0)
- 1
Funding/Support: This work was supported in part by the Prostate Cancer Foundation (F.Y.F, A.M.C), the National Institutes of Health Prostate SPORE (P50CA186786 to A.M.C) and the Early Detection Research Network (U01CA111275 and U01CA113913 to A.M.C). A.M.C. is supported by the Alfred A. Taubman Institute, Howard Hughes Medical Institute and the American Cancer Society. R.M is supported by a Department of Defense postdoctoral award (W81XWH-13-1-0284). R.M. and M.C. are supported by a Prostate Cancer Foundation Young Investigator award. The sponsors played no role in the design and conduct of the study.
- 2
Equal Contributions.
- 3
Co-senior authors.